fbpx
Couleur
C C C C C
Texte
T T
Skip To Content

Age-Related Macular Degeneration (AMD)

Reshaping the Cornea to Restore Sight

Dr. Raymond Stein is a world-renowned innovator in laser eye treatment, and has played a lead role in bringing many pioneering laser procedures to Canada. Most recently, Dr. Stein became the first…

Read More
FDA Rules Against For-Profit Stem Cell Company

Quick on the heels of last week’s Washington Post article discussing the dangers of stem cell therapy, a U.S. federal judge ruled in favour of the Food and Drug Administration (FDA) in…

Read More
Stem Cells
Restoring Vision with Stem Cells

Dr. David Gamm is a pediatric ophthalmologist investigating how stem cells can be used as a potential treatment for retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Dr. Gamm’s research is supported…

Read More
Lab Researcher
Trusting Stem Cell Therapies

Recently, an article published by the Washington Post discussed the growing number of stem cell clinics in the United States offering “cures” for conditions like age-related macular degeneration, multiple sclerosis, and Parkinson’s…

Read More
Stem Cells
Fighting Blindness Canada Calls for Safety Study Regarding the Use of Off-Label Injections to Treat Blinding Eye Diseases in British Columbia

In light of a recent article published by the Globe and Mail regarding the potential correlation between Avastin injections and increased glaucoma rates specifically in British Columbia, Fighting Blindness Canada is republishing…

Read More
Together We Will Cure Blindness
Together We Will Cure Blindness

Right now, over one million Canadians are living with blinding eye diseases and as vision fades, so too can hope. To date, donors of the Fighting Blindness Canada (FBC) have contributed more…

Read More

Unissons nos forces

Découvrez comment votre soutien peut contribuer à tracer un avenir sans cécité! Soyez informé en exclusivité des dernières percées de la recherche en santé de la vision et des événements dans votre région en vous abonnant à notre infolettre.